X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (76) 76
index medicus (60) 60
male (55) 55
female (54) 54
hematology (49) 49
sickle cell disease (42) 42
adult (41) 41
anemia, sickle cell - complications (37) 37
sickle cell anemia (36) 36
adolescent (34) 34
article (32) 32
child (30) 30
disease (23) 23
anemia (22) 22
middle aged (22) 22
young adult (22) 22
child, preschool (20) 20
children (20) 20
anemia, sickle cell - blood (16) 16
anemia, sickle cell - physiopathology (16) 16
pulmonary hypertension (16) 16
adults (14) 14
hydroxyurea (14) 14
mortality (14) 14
pediatrics (14) 14
abridged index medicus (13) 13
anemia, sickle cell - drug therapy (13) 13
anemia, sickle cell - therapy (13) 13
death (12) 12
risk factors (12) 12
treatment outcome (12) 12
oncology (11) 11
pain (11) 11
prospective studies (11) 11
pulmonary-hypertension (11) 11
hydroxyurea - therapeutic use (10) 10
hypertension (10) 10
anemia, sickle cell - genetics (9) 9
care and treatment (9) 9
hemoglobin (9) 9
hemolysis (9) 9
sickle cell (9) 9
aged (8) 8
complications (8) 8
retrospective studies (8) 8
risk-factor (8) 8
analysis (7) 7
leg ulcer - etiology (7) 7
medicine, general & internal (7) 7
patients (7) 7
ulceration (7) 7
ulcers (7) 7
combined modality therapy (6) 6
follow-up studies (6) 6
health aspects (6) 6
hypertension, pulmonary - etiology (6) 6
management (6) 6
medicine (6) 6
risk (6) 6
risk-factors (6) 6
therapy (6) 6
age factors (5) 5
biomarkers (5) 5
blood transfusion (5) 5
cohort studies (5) 5
cross-sectional studies (5) 5
echocardiography (5) 5
hemoglobins - metabolism (5) 5
hydroxycarbamide (5) 5
pain - etiology (5) 5
regurgitant jet velocity (5) 5
research article (5) 5
severity of illness index (5) 5
stroke (5) 5
survival (5) 5
tricuspid valve insufficiency - etiology (5) 5
acute chest syndrome (4) 4
analgesia, patient-controlled - methods (4) 4
analgesics, opioid - therapeutic use (4) 4
anemia, sickle cell - diagnostic imaging (4) 4
anemia, sickle cell - metabolism (4) 4
anemia, sickle cell - mortality (4) 4
anemia, sickle cell - pathology (4) 4
antisickling agents - therapeutic use (4) 4
blood pressure (4) 4
children & youth (4) 4
clinical trials (4) 4
dermatology (4) 4
drug therapy, combination (4) 4
genotype (4) 4
hemic and lymphatic diseases (4) 4
hospitalization (4) 4
human necessities (4) 4
hygiene (4) 4
infant (4) 4
inflammation (4) 4
leg ulcer (4) 4
leg ulcer - therapy (4) 4
leg ulcers (4) 4
medical or veterinary science (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Hematology, ISSN 0361-8609, 06/2017, Volume 92, Issue 6, pp. 487 - 489
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 3, pp. 292 - 294
In 2017, the U.S. Food and Drug Administration approved l -glutamine (USAN, glutamine) for the prevention of acute vaso-occlusive pain events in persons with... 
MEDICINE, GENERAL & INTERNAL | Usage | Care and treatment | Sickle cell anemia | Clinical trials | Children | Research | Health aspects | Glutamine | Oxidative stress | FDA approval | Disclosure | Sickle cell disease
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/2016, Volume 91, Issue 1, pp. 22 - 30
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9778, pp. 1663 - 1672
Journal Article
International Wound Journal, ISSN 1742-4801, 12/2016, Volume 13, Issue 6, pp. 1315 - 1324
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/2016, Volume 91, Issue 1, pp. 22 - 30
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2014, Volume 371, Issue 6, pp. 507 - 518
The stimulator of interferon genes (STING) protein bridges sensors of cytosolic DNA and the inflammatory pathway mediated by interferon-β. Activating mutations... 
MEDICINE, GENERAL & INTERNAL | FAMILIAL CHILBLAIN LUPUS | CYCLIC GMP-AMP | DNA | PROTEASOME SUBUNIT | LIPODYSTROPHY | SENSOR | MONOGENIC AUTOINFLAMMATORY DISEASES | EXPRESSION | I INTERFERON | INBORN-ERRORS | Up-Regulation | Phosphorylation | Humans | Infant | Male | Interferon-gamma - metabolism | Inflammation - metabolism | STAT1 Transcription Factor - metabolism | Skin Diseases, Vascular - genetics | Genes, Dominant | Female | Transcription, Genetic | Interferon-gamma - genetics | Cytokines - genetics | Infant, Newborn | Fibroblasts - metabolism | Skin Diseases, Vascular - metabolism | Cytokines - metabolism | Membrane Proteins - genetics | Sequence Analysis, DNA | Syndrome | Janus Kinases - antagonists & inhibitors | Lung Diseases - genetics | Pedigree | Age of Onset | Inflammation - genetics | Mutation | Pulmonary manifestations of general diseases | Blood circulation disorders | Genetic aspects | Research | Gene mutations | Risk factors | Transcription | Genes | Guanosine | Leukocytes (mononuclear) | Arthritis | Interleukin 6 | Cell activation | Vascular diseases | Lymphocytes | Cyclic GMP | Interleukin 1 | Peripheral blood | Fingers & toes | Fibroblasts | Janus kinase | Skin diseases | Children | Stat1 protein | Age | Deoxyribonucleic acid--DNA | Phenotypes | AMP | Patients | Endothelial cells | Studies | Biopsy | Ligands | Interferon | Autoimmune diseases | Apoptosis
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, p. e0186270
Background Sickle cell disease (SCD) impacts millions of individuals worldwide and more than 100,000 people in the United States. Leg ulcers are the most... 
Professional relationships | Qualitative research | Back pain | Religion | Health psychology | Genomes | Patients | Emotions | Leg | Quality of life | Studies | Pain | Social interactions | Social isolation | Ulcers | Leg ulcers | Social organization | Sickle cell disease | Interviews | Chronic illnesses
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 07/2009, Volume 52, Issue 7, pp. 838 - 841
Journal Article
British Journal of Haematology, ISSN 0007-1048, 12/2018, Volume 183, Issue 5, pp. 807 - 811
Summary Among the many vascular complications of sickle cell disease (SCD), retinopathy is the most prevalent and represents a leading cause of blindness.... 
sickle cell retinopathy | hydroxyurea | fetal haemoglobin | hydroxycarbamide | sickle cell disease | MORBIDITY | ANEMIA | HEMATOLOGY | Hemoglobin | Development and progression | Hydroxyurea | Adults | Sickle cell anemia | Blindness | Retinopathy | Demography | Hematology | Complications | Fetuses | Patients | Medical centres | Demographics | Children | Sickle cell disease | Genotypes
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2015, Volume 10, Issue 11, p. e0141706
Journal Article
Journal Article